Cold medicine

Concerto Biosciences Announces Strategic Business Development Hire

Retrieved on: 
Monday, February 6, 2023
Health, General Health, Research, Pharmaceutical, Science, Biotechnology, MBA, Cold medicine, Master of Business Administration, Master of Science, Sanofi Pasteur, Head, Biochemistry, Peter Wall Institute for Advanced Studies, Pierre and Marie Curie University, Household, Business administration, Agriculture, Partnership, Master of Advanced Studies, Environment, Business development, Microbiology, Fine chemical, Northeastern University, Concerto

Concerto Biosciences, a biotechnology company designing microbial communities that restore health to our bodies and our environment, announced today that it has appointed Didier Vingadassalom, Ph.D., MBA, as Senior Director, Business Development.

Key Points: 
  • Concerto Biosciences, a biotechnology company designing microbial communities that restore health to our bodies and our environment, announced today that it has appointed Didier Vingadassalom, Ph.D., MBA, as Senior Director, Business Development.
  • He will be responsible for maturing the team’s business development infrastructure, evaluating co-discovery and co-development partnership opportunities, and helping prioritize internal technology development directions from a business development perspective.
  • “Didier has both a deep scientific background and years of business development experience— a potent combination and a perfect match for Concerto as our first senior director of business development,” said Cheri Ackerman, CEO of Concerto.
  • “Our science team already excels at rapidly discovering optimized microbial products with our kChip platform, and Didier will help us point that unique capability at pressing, high-value opportunities in collaboration with our partners.”
    Prior to joining Concerto Biosciences, Vingadassalom was senior director, business development and head of alliance management, SQZ Biotechnologies.

Americaneagle.com Announces Launch of Customer Portal and Updated Website for At-Home Antibody Test Panel Company, ImmunoProfile

Retrieved on: 
Thursday, February 2, 2023
Cold medicine, Chickenpox, Infection, World Health Organization, API, Patient, Mumps, Health, Measles, Risk, Hepatitis A, Diphtheria, WHO, Rubella, Partnership, Tetanus, Social media, Online shopping, Vaccine

First, Americaneagle.com designed the website with a secure and confidential customer portal for purchasing ImmunoProfile's products.

Key Points: 
  • First, Americaneagle.com designed the website with a secure and confidential customer portal for purchasing ImmunoProfile's products.
  • Second, the customer portal manages multiple logistical processes including those required for medical diagnostic testing in a CLIA/CAP-certified testing laboratory and the secure delivery of the customer's confidential test results.
  • ImmunoProfile offers the first-ever at-home collection Serology Antibody Test Panel for 11 common infectious diseases.
  • The test is engineered to determine personal levels of antibody protection against multiple infectious diseases in one test panel.

Haleon and Microsoft use AI to enhance health product accessibility for people who are blind or partially sighted

Retrieved on: 
Thursday, October 13, 2022
Nexium, App Store (iOS/iPadOS), CDC, List of toothpaste brands, Ibuprofen, Policy, Android, Diclofenac, NYSE, Multimedia, Severe cognitive impairment, Microsoft, Nasdaq, Artificial intelligence, Technology, Mental health, Partnership, HLN, Health, Fibre supplements, AI, Seeing AI, Dentistry, MSFT, ChapStick, Nicorette, Centrum, 1-Docosanol, Aspirin/paracetamol/caffeine, TUMS, Wellness, Engineering, Medical device, Pharmaceutical industry, Video game console, Esomeprazole, Parodontax, Cold medicine, Fluticasone propionate, Sensodyne

REDMOND, Wash., Oct. 12, 2022 /PRNewswire/ -- On Wednesday, Haleon, a global leader in consumer health, and Microsoft Corp. announced a new collaboration to make everyday health more accessible for people who are blind, have low vision or have difficulty reading product labels due to low literacy. Together, the companies are expanding functionality in the Microsoft Seeing AI app to provide consumers with more detailed labelling information for over 1,500 Haleon products across the U.S. and U.K. Seeing AI is a free mobile app designed to help people who have trouble seeing by narrating the world around them.              

Key Points: 
  • - New enhancements in the free Microsoft Seeing AI app will help advance inclusivity and improve accessibility.
  • Seeing AI is a free mobile app designed to help people who have trouble seeing by narrating the world around them.
  • With today's launch on World Sight Day, people will hear packaging information through Seeing AI by scanning the barcode of Haleon products.
  • Haleon initiated this collaboration with Microsoft via its Seeing AI app to make consumer health more accessible, achievable and inclusive.

Centrum Silver is Now Clinically Shown to Support Cognitive Health in Older Adults

Retrieved on: 
Wednesday, September 14, 2022
VMS, Health, COSMOS, Memory, Woman, Ageing, Food, Disease, Even and odd functions, Mineral, Learning, LSE, Clinical trial, Diclofenac, HLN, Paracetamol, Ibuprofen, Science, Dementia, Research, Cognitive Function Scanner, Government budget balance, Man, Xylometazoline, Food and Drug Administration, Study, Toy, Dietary supplement, Cold medicine, Centrum, Sensodyne, Vitamin, Parodontax

WARREN, N.J., Sept. 14, 2022 /PRNewswire/ -- New study results released today on the large-scale, clinical trial COSMOS-Mind, suggests that those who took Centrum Silver demonstrated significant improvement in cognitive function in comparison to placebo. These new findings provide additional evidence on the benefits of multivitamin supplementation in older adults.

Key Points: 
  • New Study of Centrum Silver from COSMOS-Mind Demonstrates Significant Improvements in Participants' Cognitive Function.
  • These new findings provide additional evidence on the benefits of multivitamin supplementation in older adults.
  • In continuing with this strong heritage, Centrum Silver product, placebo, and packaging was provided in support of the Cocoa Supplement and Multivitamin Outcomes Study (COSMOS) trial.
  • "We know that multivitamins are a practical and effective way to complement nutrition and support general health," shared Natalie Halpern, Brand Director, Centrum US.

Nicorette is Motivating Smokers to Take Healthier Breaks with a Customized Music Listening Experience, SmokeLess Break Beats

Retrieved on: 
Wednesday, July 27, 2022
Smoke, Nexium, Brain, Smoker, Occupational burnout, Nicotine, Wellness, Heart rate, Nicotine replacement therapy, Diclofenac, Student, Music therapy, Ideation, Tobacco, NYSE, Smoking, Berklee College of Music, Solution, Fatigue, Aspirin/paracetamol/caffeine, Health, Dentistry, NRT, Marketing, Relaxation, ChapStick, Centrum, TUMS, Science, Ibuprofen, Fibre supplements, Mindfulness, Program, 1-Docosanol, Nicorette, HLN, Music, Spotify, Esomeprazole, Cold medicine, Parodontax, Fluticasone propionate, Music, Sensodyne

WARREN, N.J., July 27, 2022 /PRNewswire/ -- Today, Nicorette unveils SmokeLess Break Beats – a first-of-its kind, customized music listening experience that uses the science of music therapy to address smokers' needs and motivate them towards healthier breaks. Nicorette has partnered with Berklee Music and Health Institute to enlist 30+ students and faculty to design eight original tracks, referencing scientific research about overcoming smoking addiction. These original compositions are featured in four playlists that promote relaxation, focus, confidence, and physical release, which are key benefits smokers seek in smoke breaks. Available for free on Spotify, each playlist contains the original tracks and is personalized using the listener's music history, functioning as a break-time emotional and behavioral tool to aid in smoking cessation.

Key Points: 
  • Developed in Partnership with Berklee Music and Health Institute, Program Will Feature Original Music and Encourage Smokers to Listen During Smoke-Less Breaks.
  • WARREN, N.J., July 27, 2022 /PRNewswire/ -- Today, Nicorette unveilsSmokeLess Break Beats a first-of-its kind, customized music listening experience that uses the science of music therapy to address smokers' needs and motivate them towards healthier breaks.
  • Smoke breaks are ingrained in smoking culture, serving as "treasured moments" that routinely help smokers slow down and relax.
  • SmokeLess Break Beats is designed to help smokers keep the habit of taking breaks but replace the cigarette with listening to music instead," explained Dan Wertheim, Brand Manager, U.S. Smokers' Health, Haleon.

Haleon launches with purpose to deliver better everyday health with humanity

Retrieved on: 
Monday, July 18, 2022
London, TUMS, CEO, Pressure, Risk, Solution, Xylometazoline, Quality of life, Science, Forward-looking statement, NYSE, Technology, VMS, Hunger, New, London Stock Exchange, Ibuprofen, Humanity, GSK, Legislation, Face, Paracetamol, Multimedia, Mineral, Medicine, Diclofenac, Centrum, HLN, Nature, Empathy, Trust, LSE, Pharmaceutical industry, Online gambling, Online shopping, Parodontax, Health, Cold medicine, Vitamin, Sensodyne

WARREN, N.J., July 18, 2022 /PRNewswire/ -- Today, Haleon (LSE/NYSE: HLN) launches as an independent company 100% focused on consumer health, completing its demerger from GSK. The newly listed business is driven by its purpose to deliver better everyday health with humanity.

Key Points: 
  • The newly listed business is driven by its purpose todeliver better everyday health with humanity.
  • First, by working to remove barriers to better everyday health, and second, by aiming to empower 50 million people a year by 2025 to be more included in opportunities for better everyday health.
  • With Humanity" brings to life the essence and purpose of Haleon and was developed by its own colleagues.
  • The group employs over 22,000 people across 170 markets, who are united by Haleon's purpose - to deliver better everyday health with humanity.

WeXL Launches FREE Monthly Talks to Benefit Participants - All Welcome

Retrieved on: 
Wednesday, September 22, 2021
Marlboro, Pepsi, Thought, Cannes, Advertising, Culture, Patient, Centrum, FREE, Create, Nursing, RSVP, Pizza Hut, Industry, CEO, Knowledge, SAN, Mitsubishi, WCHB, Founder, COVID-19, Kawasaki, Mountain Dew, Nescafé, Cannes Lions International Festival of Creativity, PST, Cold medicine, Time, Entertainment

SAN FRANCISCO, Sept. 21, 2021 /PRNewswire-PRWeb/ -- WeXL launches the first of its FREE new monthly series highlighting the best global creative professionals that aims to help participants discover their passion, purpose and story.

Key Points: 
  • SAN FRANCISCO, Sept. 21, 2021 /PRNewswire-PRWeb/ -- WeXL launches the first of its FREE new monthly series highlighting the best global creative professionals that aims to help participants discover their passion, purpose and story.
  • "Whether it's gender, racial, economic, or neurodiversity, we are all connected across the board through our passion, purpose and story," says CEO and Founder of WeXL, Arabella DeLucco.
  • We are so fortunate to have these amazing creatives willing to share their time, knowledge and stories."
  • Nick Santiago and Tom Conigliaro will share what they have learned in their 15+ years of creating in the industry.

Ohio Becomes 21st State to Adopt Age-18 Sales Law for Cough Medicine

Retrieved on: 
Thursday, July 1, 2021
Public policy, Government, General Health, Health, State, Local, Psychoactive drugs, Drugs, Antitussives, Morphinans, Cold medicine, Dextromethorphan, Common cold, CHPA

When used as directed, DXM is a safe and effective cough suppressant found in OTC cough and cold products.

Key Points: 
  • When used as directed, DXM is a safe and effective cough suppressant found in OTC cough and cold products.
  • CHPA thanks Governor DeWine for signing this important bill into law, as well as Representative Koehler for his tireless leadership on this issue, said Melville.
  • Smart public policy and education are both vitally important to combating teen OTC cough medicine abuse.
  • In 2012, California became the first state to prohibit sales of DXM-containing products to minors.

Two Day Online Course: FDA's Regulation of OTC Drug Products - What It Is, How to Analyze It, Make It Work for You (August 10-11, 2021) - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 26, 2021
Health, Pharmaceutical, Health care, Health, Pharmaceuticals policy, Drugs, Drug Safety, Over-the-counter drug, Medication, Food and Drug Administration, Ibuprofen, Cold medicine, Antipruritic, Decongestant

The "FDA's Regulation of OTC Drug Products - What It Is, How to Analyze It, Make It Work for You" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "FDA's Regulation of OTC Drug Products - What It Is, How to Analyze It, Make It Work for You" conference has been added to ResearchAndMarkets.com's offering.
  • Available without a prescription and for purchase directly off-the-shelf, OTC drug products currently represent nearly 60% of all drug products sold in the United States.
  • Some of the most recognized OTC drug products include ibuprofen tablets, anti-itch creams, nasal decongestant sprays, cough syrups, antacids, allergy medicines and topical pain relievers.
  • The U.S. Food and Drug Administration ("FDA") is responsible for the regulation and oversight of the U.S. OTC drug market.

Insights on the Cough Syrup Global Market to 2027 - Opportunity Analysis and Industry Forecasts - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 25, 2021
Health, Pharmaceutical, Psychoactive drugs, Antitussives, Cold medicine, Lean, Cough, Drugs, Clinical medicine

The "Cough Syrup Market by Product Type, Age Group and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cough Syrup Market by Product Type, Age Group and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global cough syrup market was valued at $5,232.73 million in 2019, and is projected to reach $6,108.25 million by 2027, registering a CAGR of 2.8% from 2020 to 2027.
  • The growth of the global cough syrup market is majorly driven by rise in respiratory disorders.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global cough syrup market.